Related Experiment Video
Updated: Jul 1, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth
Hui Xu1, Yan-Long Liu, Yan-Mei Yang
1Department of Oncosurgery, The Affiliated 4th Hospital of Harbin Medical University, 37 Yiyuan Street, Nangang District, Harbin, 150001, People's Republic of China.
Purpose:
Increasing experimental evidences suggest that ubiquitin-specific protease 22 (USP22), a cancer stem cell marker, plays a crucial role in pathological processes of epithelial malignancies and other solid tumors, which makes it a potential target for cancer therapy. The aim of this study was to study the roles of USP22 in human colorectal cancer cell line HCT116 by suppressing USP22 expression with micro-interfering RNA (miRNA).
Methods:
With the knock-down of USP22, the changes of cellular proliferation, cell cycle, cell apoptosis, and major vault protein (MVP) expression were investigated. Furthermore, a tumor xenograft model in nude mice was injected with USP22 miRNA silencing vector and the immunohistochemical staining was performed to evaluate the USP22 expression in the tumor.
Results:
The knock-down of USP22 protein expression by miRNA resulted in the inhibition of cellular proliferation, the accumulation of cells in the G1 phase, the reduction of apoptosis, and the down-regulation of MVP expression. Furthermore, with orthotopic mice as a model, tumor growth was suppressed when USP22 miRNA silencing vector was injected. Immunohistochemical analyses of tumor sections revealed that USP22 expression in animals decreased when USP22 expression was inhibited by miRNA.
Conclusion:
These results support the hypothesis that USP22 plays a crucial role in tumor formation and growth by regulating cell proliferation with USP22-dependent signaling pathway. Furthermore, USP22 acts as a major transcriptional factor to regulate MVP drug resistant gene. Taken together, targeting USP22 may offer additional possibilities in cancer therapy.
Insights
Targeting ubiquitin-specific protease 22 (USP22) may inhibit colorectal cancer growth. Suppressing USP22 with micro-interfering RNA (miRNA) reduced cell proliferation and tumor growth in mice, suggesting USP22 as a potential cancer therapy target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ubiquitin-specific protease 22 (USP22) is implicated in epithelial malignancies and solid tumors.
- USP22 functions as a cancer stem cell marker, indicating its potential as a therapeutic target.
- Understanding USP22's role in colorectal cancer is crucial for developing novel treatment strategies.
Purpose of the Study:
- To investigate the functional role of USP22 in the human colorectal cancer cell line HCT116.
- To suppress USP22 expression using micro-interfering RNA (miRNA) and assess its effects on cancer progression.
- To evaluate USP22 as a potential therapeutic target for colorectal cancer.
Main Methods:
- USP22 expression was suppressed in HCT116 cells using miRNA.
- Cellular proliferation, cell cycle, and apoptosis were analyzed post-USP22 knockdown.
- A tumor xenograft model in nude mice was utilized to assess the in vivo effects of USP22 inhibition.
- Immunohistochemical staining was performed to evaluate USP22 expression in tumor tissues.
Main Results:
- USP22 knockdown significantly inhibited cellular proliferation and induced G1 phase cell cycle arrest.
- Apoptosis was reduced, and Major Vault Protein (MVP) expression was downregulated following USP22 suppression.
- In vivo studies demonstrated suppressed tumor growth in mice treated with USP22 miRNA silencing vector.
- Immunohistochemistry confirmed decreased USP22 expression in tumors after miRNA intervention.
Conclusions:
- USP22 plays a critical role in colorectal tumor formation and growth, partly through regulating cell proliferation via a USP22-dependent pathway.
- USP22 acts as a transcriptional factor regulating the drug-resistant gene MVP.
- Targeting USP22 presents a promising therapeutic strategy for colorectal cancer and potentially other malignancies.
Related Concept Videos
MicroRNAs
Experimental RNAi
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
MicroRNAs

